中國天楹(000035.SZ):2019年淨利預增219%-237%
格隆匯1月15日丨中國天楹(000035.SZ)披露2019年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為6.9億元-7.3億元,同比增長219%-237%;基本每股收益約0.2921元-0.3090元。業績變動原因如下:
2019年1月11日,公司以發行股份及支付現金的方式收購江蘇德展投資有限公司100%股權事項完成股權變更,發行的股份於2019年2月1日在深圳證券交易所上市,2018年同期數據未包括江蘇德展投資有限公司的盈利情況,而本公告預計的2019年1-12月業績則包括了江蘇德展投資有限公司2019年2月-12月的盈利情況,所以公司2019年度淨利潤較上年同期大幅度增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.